US-Germany rift could scupper vaccine patent waiver
A bold US bid to waive patents on much-needed coronavirus vaccines was strongly opposed by Germany on Thursday (6 May), threatening to derail the proposal that requires the consensus of World Trade Organisation members to pass.
Responses